Lasa Supergenerics Limited (BOM:540702)
India · Delayed Price · Currency is INR 8.81
+0.09 (1.03%)
At close: Feb 13, 2026
Lasa Supergenerics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 644.1 | 1,424 | 1,043 | 1,296 | 1,371 | 2,024 |
Other Revenue | 25.51 | 50.12 | 0.99 | 8.62 | - | - |
Revenue | 669.61 | 1,475 | 1,044 | 1,304 | 1,371 | 2,024 |
Revenue Growth (YoY) | -47.77% | 41.20% | -19.93% | -4.88% | -32.24% | 21.00% |
Cost of Revenue | 518.06 | 1,062 | 752.18 | 1,075 | 897.68 | 1,163 |
Gross Profit | 151.55 | 412.73 | 292.17 | 229.09 | 473.59 | 860.47 |
Selling, General & Admin | 35.53 | 61.08 | 63.42 | 79.64 | 73.77 | 144.82 |
Other Operating Expenses | 108.85 | 238.87 | 206.1 | 187.62 | 207.24 | 243 |
Operating Expenses | 230.48 | 422.95 | 376.24 | 401.45 | 426.12 | 546.06 |
Operating Income | -78.93 | -10.22 | -84.08 | -172.36 | 47.47 | 314.41 |
Interest Expense | -3.65 | -26.92 | -19.32 | -41.54 | -0.25 | -16.76 |
Interest & Investment Income | - | - | - | 0.27 | 0.85 | 0.49 |
Currency Exchange Gain (Loss) | - | - | - | -16.42 | -7.3 | 1.17 |
Other Non Operating Income (Expenses) | - | -0 | 0 | -0.36 | -0.28 | -3.8 |
EBT Excluding Unusual Items | -82.58 | -37.14 | -103.39 | -230.41 | 40.5 | 295.52 |
Merger & Restructuring Charges | - | - | - | - | - | -0.5 |
Gain (Loss) on Sale of Assets | - | - | - | 6.72 | 0.94 | -0.1 |
Other Unusual Items | -444.89 | -156.69 | -87.73 | -198.97 | -102.83 | - |
Pretax Income | -527.48 | -193.83 | -191.12 | -422.65 | -61.39 | 294.91 |
Income Tax Expense | -85.31 | -46.26 | 26.18 | -36.44 | -8.08 | 67.14 |
Net Income | -442.17 | -147.57 | -217.31 | -386.21 | -53.31 | 227.78 |
Net Income to Common | -442.17 | -147.57 | -217.31 | -386.21 | -53.31 | 227.78 |
Net Income Growth | - | - | - | - | - | 527.76% |
Shares Outstanding (Basic) | 49 | 50 | 50 | 50 | 50 | 41 |
Shares Outstanding (Diluted) | 49 | 50 | 50 | 50 | 50 | 41 |
Shares Change (YoY) | -4.88% | -0.09% | -0.06% | -0.39% | 23.66% | - |
EPS (Basic) | -9.07 | -2.95 | -4.34 | -7.71 | -1.06 | 5.60 |
EPS (Diluted) | -9.07 | -2.95 | -4.34 | -7.71 | -1.06 | 5.60 |
EPS Growth | - | - | - | - | - | 529.21% |
Free Cash Flow | - | -28.24 | 1.71 | -173 | 92.12 | 347.24 |
Free Cash Flow Per Share | - | -0.56 | 0.03 | -3.45 | 1.83 | 8.54 |
Dividend Per Share | - | - | - | - | 0.250 | 0.250 |
Gross Margin | 22.63% | 27.99% | 27.98% | 17.56% | 34.54% | 42.52% |
Operating Margin | -11.79% | -0.69% | -8.05% | -13.21% | 3.46% | 15.54% |
Profit Margin | -66.03% | -10.01% | -20.81% | -29.61% | -3.89% | 11.25% |
Free Cash Flow Margin | - | -1.92% | 0.16% | -13.26% | 6.72% | 17.16% |
EBITDA | 55.68 | 112.4 | 22.53 | -38.17 | 192.58 | 472.65 |
EBITDA Margin | 8.32% | 7.62% | 2.16% | -2.93% | 14.04% | 23.36% |
D&A For EBITDA | 134.62 | 122.61 | 106.61 | 134.19 | 145.11 | 158.24 |
EBIT | -78.93 | -10.22 | -84.08 | -172.36 | 47.47 | 314.41 |
EBIT Margin | -11.79% | -0.69% | -8.05% | -13.21% | 3.46% | 15.54% |
Effective Tax Rate | - | - | - | - | - | 22.77% |
Revenue as Reported | 669.61 | 1,475 | 1,044 | 1,314 | 1,374 | 2,024 |
Advertising Expenses | - | - | - | 3.24 | 0.34 | 0.5 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.